3D Printing: A Promising Revolutionary Technology in Pharmaceutical Drug Development and Health Car
DOI:
https://doi.org/10.37285/ijpsn.2023.16.1.7Abstract
The three-dimensional (3D) printing technique is an emerging paradigm shift in the field of drug manufacturing. It also proved to be a promising technology with respect to the pharmaceutical, clinical medicine, and regulatory sciences. It is a modern additive manufacturing technology in which digital information is used to produce a physical model. Unlike other subtractive and formative manufacturing processes which involve removing sections of material by machining or by cutting it away, in 3D printing technology objects are prepared from 3D model data in the process of joining materials layer by layer. In drug therapy, 3D printing has abundant opportunities for rapid preparation of multifunctional customized drug delivery systems with improved drug release features, flexible and personalized dosage forms, implants matching specific patient anatomical needs as well as cell-based materials for regenerative drug therapy and prosthesis. The 3D printing methods have gained vast importance in the field of pharmaceutical and medical applications. It is an interdisciplinary approach with the aim of exploring newer drug-delivery systems. 3D printing could also become a part of the drug production line in the pharmaceutical industry which tends to move towards personalized medicine along with mass manufacture. Presently 3D printing technology is broadly investigated in the field of drug delivery after the approval of the first 3D printed tablet containing an antiepileptic drug, levetiracetam under the trade name of Spritam® by Aprecia Pharmaceuticals in 2015. The present review recapitulates the novel applications of 3D printing technology in the field of pharmaceutical drug development and health care. It also reviews the working principle of various techniques of 3D printing along with their advantages and disadvantages.
Downloads
Metrics
Keywords:
3D printing technology, Personalized Therapy, 3D printed dosage forms, Customized drug delivery systems, Patient compliance
Downloads
Published
How to Cite
Issue
Section
References
Jamroz W, Szafraniec J, Kurek M, Jachowicz R. 3D Printing in Pharmaceutical and Medical Applications Recent Achievements and Challenges. Pharm Res 35. 2018. p. 176.
Begines B et al. Design of highly stabilized nanocomposite inks based on biodegradable polymer matrix and gold nanoparticles for Inkjet Printing. Scientific Reports. 2019. 9, 16097
Kejing S, Deck K, Nokhodchi A. Mohammed M. Drop-On-Powder 3D Printing of Tablets with an Anti-Cancer Drug. 5-Fluorouracil. Pharmaceutics. 2019 11.p.150.
Tian P, Yang F, Yuan X, Min-Mei L, Li-Ping Y, Wei L, Qi-Feng L, Zhu-Fen L, Si-Yu H & Yan- Zhong Coral disintegrating patient-tailored tablets of warfarin sodium produced by 3D printing. Drug Development and Industrial Pharmacy. 2018. 44(12):1918-1923
Goyanes A, Scarpa M, Kamlow M, Gaisford S, Basit, AW, Orlu M. Patient acceptability of 3D printed medicines. Int. J. Pharm. 530. 2017 p. 71–78.
Kollamaram G, Croker DM, Walker GM, Goyanes A, Basit AW, Gaisford S. Low temperature fused deposition modeling fdm 3D printing of thermolabile drugs. Int. J. Pharm. 545, 2018. p.144–152.
Oblom H, Zhang J, Pimparade M, Speer I, Preis M, Repka, M, Sandler N. 3D-printed isoniazid tablets for the treatment and prevention of tuberculosis—personalized dosing and drug release. AAPS Pharmscitech, 2019. p. 20-52.
Alhnan MA, Okwuosa TC, Sadia M, Wan KW, W Ahmed, B Arafat. Emergence of 3D printed dosage forms: Opportunities and challenges. Pharm. Res. 33. 2016. p.1817–1832.
Madla CM, Trenfield SJ, Goyanes A, Gaisford S, Basit AW. 3D printing technologies, implementation and regulation: An overview. Eds.; Springer International Publishing: Cham. Switzerland. 2018. p. 21–40.
Shaban A, Jonathan Burley C, Morgan Alexander R, Jing Y, Clive R J. 3D printing of five-in-one dose combination polypill with defined immediate and sustained release profiles. Journal of Controlled Release 217. 2015. p. 308–314.
Krause J, Bogdahn M, Schneider F. Design and characterization of a novel 3D printed pressure-controlled drug delivery system. European Journal of Pharmaceutical Sciences. 2019.
Pingfei L, Zhang S, Sun W, Mengsuo C, Wen H, Li Q, Weisan P, and Xinggang Y. Flexibility of 3D Extruded Printing for a Novel Controlled-Release Puerarin Gastric Floating Tablet: Design of Internal Structure. AAPS Pharm Sci Tech 2019. 20:236.
Jamroz W, Kurek M, Czech A, Szafraniec J, Gawlak K, Jachowicz R. 3D printing of tablets containing amorphous aripiprazole by filaments co-extrusion. Eur J Pharm Biopharm. 2018. Oct.131. p. 44-47
Christos I. Gioumouxouzis, Baklavaridis A, Orestis LK, Catherine K. Markopoulou, Nikolaos B, Dimitrios T, Dimitrios G.Fatouros. A 3D printed bilayer oral solid dosage form combining metformin for prolonged and glimepiride for immediate drug delivery. European Journal of Pharmaceutical Sciences, Volume 120, 30, 2018. p.40-52
Goyanes A, Buanz AB, Hatton GB, Gaisford S, Basit AW. 3D printing of modified-release aminosalicylate 4-ASA and 5-ASA tablets: Eur J Pharm Biopharm. 89. 2015. P.157-62.
Goyanes A, Madla CM, Umerji A, Duran Pineiro G, Giraldez Montero JM, Lamas Diaz MJ, Gonzalez Barcia M, Taherali F, Sanchez Pintos P, Couce ML. Automated therapy preparation of isoleucine formulations using 3D printing for the treatment of MSUD: First single-centre, prospective, crossover study in patients. Int. J. Pharm. 2019. 567-118497.
Khaled S, Burley JC, Alexander MR, Yang J, Roberts CJ. 3D printing of tablets containing multiple drugs with defined release profiles. Int. J. Pharm. 494. 2015. p. 643–650.
Khaled S, Burley J, Alexander M, Roberts CJ. Desktop 3D printing of controlled release pharmaceutical bilayer tablets. Int. J. Pharm. 461. 2014. p.105–111.
Linares V, Casas M, Caraballo I. Printfills: 3D printed systems combining fused deposition modelling and injection volume filling. Application to colon-specific drug delivery. Eur. J. Pharm. Biopharm. 134. 2019.p. 138–143.
Araujo MRP, Barreto LLS, Gratieri T, Gelfuso GM, Filho CM. The digital pharmacies era: How 3D printing technology using fused deposition modeling can become a reality. Pharmaceutics. 2019.p.11, 128.
Sadia M, So Snicka A, Arafat B, Isreb A, Ahmed W, Kelarakis A, Alhnan MA Adaptation of pharmaceutical excipients to FDM 3D printing for the fabrication of patient-tailored immediate release tablets. Int. J. Pharm. 2016. 513. p. 659–668.
Nour A, Fina F, Marcuta C, Kraschew L, Wolfgang M, Gaisford Simon, W. Basit A, and Goyanes A, e Laser Sintering S. 3D Printing of Orally Disintegrating Printlets Containing Ondansetron. Pharmaceutics. 2020.p. 12- 110
Jie W, Alvaro G, Simon G, Abdul BW. Stereolithographic SLA 3D printing of oral modified-release dosage forms. International Journal of Pharmaceutics. Volume 503. Issues 1–2. 2016. p. 207-212.
Martinez PR, Goyanes A, Basit AW, Gaisford S. Fabrication of drug-loaded hydrogels with stereolithographic 3D printing. Int J Pharm. 5321. 2017.p. 313-317.
Healy AV, Fuenmayor E, Doran P, Geever LM, Higginbotham CL, Lyons JG. Additive manufacturing of personalized pharmaceutical dosage forms via stereolithography. Pharmaceutics 2019. 11 p.645.
Robles Martinez P, Xu X, Trenfield, SJ, Awad A, Goyanes A, Telford R, Basit AW, Gaisford S. 3D printing of a multi-layered polypill containing six drugs using a novel stereolithographic method. Pharmaceutics, 2019. 11 p. 274.
Xu X, Martinez RP, Madla CM, Goyanes A, Joubert F, Basit AW, Gaisford S .Stereolithography SLA 3D printing of an antihypertensive polyprintlet: Case study of an unexpected photopolymer-drug reaction. Addit. Manuf. 2020.p. 101071.
Yan Y, Yanjun Z, Xiao L, Qingliang Y, Gengshen Y. Printability of External and Internal Structures Based on Digital Light Processing 3D Printing Technique. Pharmaceutics. 2020. 12. p. 207
Krkobabic M, Medarevic D, Cvijic S, Grujic B, Ibric S. Hydrophilic excipients in digital light processing DLP printing of sustained release tablets: Impact on internal structure and drug dissolution rate. Int. J. Pharm. 2019. 572. p. 118790
Kadry H, Wadnap S, Xu C, Ahsan F. Digital light processing DLP 3D-printing technology and photoreactive polymers in fabrication of modified-release tablets. Eur. J. Pharm. Sci. 2019. 135. p. 60–67.
Vithani K, Goyanes A, Jannin V, Basit AW, Gaisford S, Boyd BJ. A proof of concept for 3D printing of solid lipid-based formulations of poorly water-soluble drugs to control formulation dispersion kinetics. Pharm. Res. 2019. 36. p. 102.
Kapilkumar V, Alvaro G, Vincent J, Abdul W B, Simon G, BJ Ben An Overview of 3D Printing Technologies for Soft Materials and Potential Opportunities for Lipid-based Drug Delivery Systems. Pharm Res 2019. 36. p. 4
Alvaro G, Nour A, Sarah TJ, Edmont S, Simon G, Abdul BW. Direct powder extrusion 3D printing: Fabrication of drug products using a novel single-step process. International Journal of Pharmaceutics. 2019. P. 567 -118471
Conceicao J, Vaamonde F, Goyanes A, Adeoye O, Concheiro A, Cabral MH, Sousa Lobo JM, Alvarez L. Hydroxypropyl-cyclodextrin-based fast dissolving carbamazepine print let’s prepared by semisolid extrusion 3D printing: Carbohydr. Polym. 2019.p. 221, 55–6
Ian G, David R, Brent S. Additive Manufacturing Technologies 3D Printing: Rapid Prototyping and Direct Digital Manufacturing Second Edition. Springer New York Heidelberg Dordrecht London. 2015.
Zeeshan F, Madheswaran T, Pandey M, Gorain B. Three-Dimensional 3-D Printing Technology Exploited for the Fabrication of Drug Delivery Systems: Curr Pharm Des. 2018. 2442. p. 5019-5028.
Chandekar A, Mishra DK., Sharma S, Saraogi GK,Gupta U, Gupta G. 3D Printing Technology: A New Milestone in the Development of Pharmaceuticals. Current Pharmaceutical Design, 2019. Volume 25, Issue 9. p.937-945
Martinez PR, Goyanes A, Basit AW, Gaisford S. Influence of Geometry on the Drug Release Profiles of Stereolithographic SLA 3D-Printed Tablets. AAPS Pharm Sci Tech. 2018 Nov. 198 p. 3355-3361.
Zema L, Melocchi A, Maroni A, Gazzaniga A. Three-dimensional printing of medicinal products and the challenge of personalized therapy. J. Pharm. Sci. 2017. 106. P. 1697–1705.
Trenfield SJ, Xian Tan H, Awad A, Buanz A, Gaisford S, Basit Goyanes AW. Track-and-trace: Novel anti-counterfeit measures for 3D printed personalized drug products using smart material inks. Int. J. Pharm. 2019.p. 567- 118443.
Scoutaris N. 3D printed Starmix drug loaded dosage forms for paediatric applications. Pharm. 2018. p. 35- 34.
Elliott I. The practice and clinical implications of tablet splitting in international health. Trop. Med. Int. Health. 2014. 19. P. 754–760.
Goyanes A, Det-Amornrat U, Wang J, Basit AW, Gaisford S. 3D scanning and 3D printing as innovative technologies for fabricating personalized topical drug delivery systems. J Control Release. 2016. 234. p. 41-8.
Kotta S, Nair A, Alsabeelah N. 3D Printing Technology in Drug Delivery: Recent Progress and Application. Current Pharmaceutical Design. 2018. 24. p. 5039-5048
Anna A, Augusto P, Bernardo I. The Role of 3D Printing in Medical Applications: A State of the Art. Hindawi Journal of Healthcare Engineering, Article ID 5340616. 2019.p.10 pages
Afsana, Jain V, Haider N, Jain K. 3D Printing in Personalized Drug Delivery. Current Pharmaceutical Design. 2018. Vol. 24 42. p.5039-63.
Trenfield SJ, Awad A, Goyanes A, Gaisford S, Basit AW. 3D printing pharmaceuticals: Drug development to frontline care. Trends Pharmacol. Sci. 2018. 39. p. 440–451.
James N, Rapti D, Christine Moore MV, Mansoor Khan A, Khairuzzaman Akm. A new chapter in pharmaceutical manufacturing: 3D-printed drug products. Advanced Drug Delivery Reviews. 2017. 108. p. 39–50.
Huang W, Zheng Q, Sun W, Xu H, Yang X. Levofloxacin implants with predefined microstructure fabricated by three-dimensional printing techniques. Int J Pharm. 2007. 339 1-2. P.33–8.
Wu W, Zheng Q, Guo X, Sun J, Liu Y. A programmed release multi-drug implant fabricated by three-dimensional printing technology for bone tuberculosis therapy. Biomed Mater. 2009. 46. p. 065005
Daly R, Harrington TS, Martin GD, Hutchings IM. Inkjet printing for pharmaceutics–a review of research and manufacturing. Int J Pharm. 2015. 4942. p. 554–67.
Kyobula M, Adedeji A, Alexander MR, Saleh E, Wildman R, Ashcroft I. 3D inkjet printing of tablets exploiting bespoke complex geometries for controlled and tuneable drug release. J Control Release. 2017. 261. p. 207–15.
Yu DG, Yang XL, Huang WD, Liu J, Wang YG, Xu H. Tablets with material gradients fabricated by three-dimensional printing. J Pharm Sci. 2007. 969. p.2446–56.
Rowe C, Katstra W, Palazzolo R, Giritlioglu B, Teung P, Cima M Multi mechanism oral dosage forms fabricated by three-dimensional printing™. J Control Release. 2000. 661. p.11–7.
Chockalingam K, Jawahar N, Chandrasekhar U. Influence of layer thickness on mechanical properties in stereolithography. Rapid Prototyp J. 2006. 122. p.106–13.
Lee BK, Yun YH, Choi JS, Choi YC, Kim JD, Cho YW. Fabrication of drug-loaded polymer microparticles with arbitrary geometries using a piezoelectric inkjet printing system. Int J Pharm. 2012. 4272. p. 305-10.
Clark EA, Alexander MR, Irvine DJ, Roberts CJ, Wallace MJ.3D printing of tablets using inkjet with UV photo initiation Int J of Pharm. 2017. 5291-2. p.523-30.
Awad A, Fina F, Trenfield, Sarah J, Patel P, Goyanes A, Gaisford S, and Basit AW. 3D Printed Pellets Miniprintlets: A Novel, Multi-Drug, Controlled Release Platform Technology. Pharmaceutics 2019. 114. p.148
Gioumouxouzis CI, Katsamenis OL, Bouropoulos N, Fatouros DG. 3D printed oral solid dosage forms containing hydrochlorothiazide for controlled drug delivery. J. Drug Deliv. Sci. Tec. 2017. 40. p. 164–171.
Yi HG, Choi YJ, Kang KS. A 3D-printed local drug delivery patch for pancreatic cancer growth suppression. J Control Release. 2016. 238. p.231-41
Genina N, Boetker JP, Colombo S, Harmankaya N, Rantanen J, Bohr A. Anti-tuberculosis drug combination for controlled oral delivery using 3D printed compartmental dosage forms: From drug product design to in vivo testing. J. Control. Release. 2017. 268. P. 40–48.
Beck RCR, Chaves PS, Goyanes A, Vukosavljevic B, Buanz A, Windbergs M, Basit AW, Gaisford S.3D printed tablets loaded with polymeric nanocapsules: An innovative approach to produce customized drug delivery systems. Int. J. Pharm. 2017. 528, 268–279.
Sadia M, Arafat B, Ahmed, Forbes W, Alhnan MA. Channelled tablets: An innovative approach to accelerating drug release from 3D printed tablets. J. Control. Release. 2018. 269. p. 355–363.
Skowyra J, Pietrzak K, Alhnan MA. Fabrication of extended release patient-tailored prednisolone tablets via fused deposition modelling FDM 3D printing. Eur J Pharm Sci. 2015. 68. p. 11-7.
